Literature DB >> 18265946

PTPL1: a large phosphatase with a split personality.

Ogan D Abaan1, Jeffrey A Toretsky.   

Abstract

Protein tyrosine phosphatase, PTPL1, (also known as PTPN13, FAP-1, PTP-BAS, PTP1E) is a non-receptor type PTP and, at 270 kDa, is the largest phosphatase within this group. In addition to the well-conserved PTP domain, PTPL1 contains at least 7 putative macromolecular interaction domains. This structural complexity indicates that PTPL1 may modulate diverse cellular functions, perhaps exerting both positive and negative effects. In accordance with this idea, while certain studies suggest that PTPL1 can act as a tumor-promoting gene other experimental studies have suggested that PTPL1 may function as a tumor suppressor. The role of PTPL1 in the cancer cell is therefore likely to be both complex and context dependent with possible roles including the modulation of growth, stress-response, and cytoskeletal remodeling pathways. Understanding the nature of molecular complexes containing PTPL1, its interaction partners, substrates, regulation and subcellular localization are key to unraveling the complex personality of this protein phosphatase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18265946      PMCID: PMC3682929          DOI: 10.1007/s10555-008-9114-2

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  74 in total

1.  EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase.

Authors:  Amparo Palmer; Manuel Zimmer; Kai S Erdmann; Volker Eulenburg; Annika Porthin; Rolf Heumann; Urban Deutsch; Rüdiger Klein
Journal:  Mol Cell       Date:  2002-04       Impact factor: 17.970

Review 2.  Structural and evolutionary relationships among protein tyrosine phosphatase domains.

Authors:  J N Andersen; O H Mortensen; G H Peters; P G Drake; L F Iversen; O H Olsen; P G Jansen; H S Andersen; N K Tonks; N P Møller
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 3.  Dual role for p75(NTR) signaling in survival and cell death: can intracellular mediators provide an explanation?

Authors:  Vidya Mamidipudi; Marie W Wooten
Journal:  J Neurosci Res       Date:  2002-05-15       Impact factor: 4.164

4.  Temporal pattern of NFkappaB activation influences apoptotic cell fate in a stimuli-dependent fashion.

Authors:  Chenguang Fan; Jusan Yang; John F Engelhardt
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

Review 5.  Mechanisms and functions of Eph and ephrin signalling.

Authors:  Klas Kullander; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2002-07       Impact factor: 94.444

6.  Identification of two Fas-associated phosphatase-1 (FAP-1) promoters in human cancer cells.

Authors:  S Irie; Y Li; H Kanki; T Ohyama; L L Deaven; S Somlo; T A Sato
Journal:  DNA Seq       Date:  2001

7.  Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks.

Authors:  J Khan; J S Wei; M Ringnér; L H Saal; M Ladanyi; F Westermann; F Berthold; M Schwab; C R Antonescu; C Peterson; P S Meltzer
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

8.  Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl.

Authors:  Hidehiko Kawai; Linghu Nie; Zhi-Min Yuan
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

9.  The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts.

Authors:  Stephen L Lessnick; Caroline S Dacwag; Todd R Golub
Journal:  Cancer Cell       Date:  2002-05       Impact factor: 31.743

10.  FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis.

Authors:  H Ungefroren; M L Kruse; A Trauzold; S Roeschmann; C Roeder; A Arlt; D Henne-Bruns; H Kalthoff
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

View more
  27 in total

1.  Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells.

Authors:  Carolina Castilla; M Luz Flores; José M Conde; Rafael Medina; Francisco J Torrubia; Miguel A Japón; Carmen Sáez
Journal:  Clin Exp Metastasis       Date:  2012-01-25       Impact factor: 5.150

2.  Expression phenotype changes of EBV-transformed lymphoblastoid cell lines during long-term subculture and its clinical significance.

Authors:  J-E Lee; H-Y Nam; S-M Shim; G-R Bae; B-G Han; J-P Jeon
Journal:  Cell Prolif       Date:  2010-08       Impact factor: 6.831

3.  PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.

Authors:  Murielle Glondu-Lassis; Mathilde Dromard; Magali Lacroix-Triki; Philippe Nirdé; Carole Puech; Dora Knani; Dany Chalbos; Gilles Freiss
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

4.  Peptide Binding to a PDZ Domain by Electrostatic Steering via Nonnative Salt Bridges.

Authors:  Nicolas Blöchliger; Min Xu; Amedeo Caflisch
Journal:  Biophys J       Date:  2015-05-05       Impact factor: 4.033

5.  Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.

Authors:  Satoshi Kawano; Wataru Ikeda; Megumi Kishimoto; Hisakazu Ogita; Yoshimi Takai
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

6.  A missense methionine mutation augments catalytic activity but reduces thermal stability in two protein tyrosine phosphatases.

Authors:  Anthony C Bishop
Journal:  Biochem Biophys Res Commun       Date:  2016-11-02       Impact factor: 3.575

7.  Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.

Authors:  Michael J Lace; James R Anson; Jens P Klussmann; Dong Hong Wang; Elaine M Smith; Thomas H Haugen; Lubomir P Turek
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

Review 8.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

9.  Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway.

Authors:  A C Hoover; G L Strand; P N Nowicki; M E Anderson; P D Vermeer; A J Klingelhutz; A D Bossler; J V Pottala; W J A J Hendriks; J H Lee
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

Review 10.  Protein tyrosine phosphatases in glioma biology.

Authors:  Anna C Navis; Monique van den Eijnden; Jan T G Schepens; Rob Hooft van Huijsduijnen; Pieter Wesseling; Wiljan J A J Hendriks
Journal:  Acta Neuropathol       Date:  2009-11-21       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.